It took me weeks to come to terms with the fact that there were no easy answers. I couldn't change the past or the diagnosis, so I focused on educating myself and becoming Tinslee's biggest advocate. We underwent all the necessary tests, scans, and procedures, and spent a year going in for lab work and check-ups.
Directory
![](https://fanconi.org/wp-content/uploads/2018/04/jacob-208x208@2x-274-1531418154.jpg)
Jacob Corn
Professor of Genome Biology | PhD | Berkeley, USA
The Corn Lab develops and uses next-generation genome editing and regulation technologies. They work on both fundamental biological discovery and potential therapies for human genetic diseases. Our focus is the mechanisms by which cells repair their DNA, maintain and differentiate hematopoietic stem cells, and use ubiquitin signaling to propagate cellular signals. Through technology development, mechanistic cellular biochemistry, and translational projects, they are working to unravel complex cellular phenotypes to further biological understanding and improve human health.
Jacob is committed to the improvement of human health through the fundamental understanding of disease mechanisms. Over the last fifteen years he has bridged academia and industry, working in therapeutic areas that include infectious disease, neurobiology, and oncology. His graduate studies at the University of California, Berkeley redefined our understanding of DNA replication and his postdoctoral work at the University of Washington computationally designed protein inhibitors from scratch. Prior to joining the Innovative Genomics Institute, Jacob was a group leader at Genentech where he discovered biological mechanisms for challenging therapeutic targets. In his spare time, Jacob enjoys long backpacking trips and rock climbing.
FA Research Projects
The Latest
News & Events
![](https://fanconi.org/wp-content/uploads/2024/07/Tinslee-1024x683.jpeg)
![](https://fanconi.org/wp-content/uploads/2024/07/Isis-scaled-e1721144755695-1024x987.jpg)
The Fanconi Cancer Foundation (FCF) is excited to announce that Dr. Isis Sroka has been named CEO effective August 1, 2024. She succeeds Mark Quinlan who served as Executive Director since 2017 and recently announced his departure. Quinlan will continue in an advisory role with FCF through a transition period.
![](https://fanconi.org/wp-content/uploads/2024/07/PXL_20240524_145121333-1024x771.jpg)
On May 24th, 2024, the FA Europe Network hosted its inaugural pan-European scientific meeting at the historic Saint-Louis Hospital in Paris, marking a significant milestone in international collaboration for Fanconi anemia (FA).